Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
MoneyGram Payment Systems Agrees to Pay OFAC $34k for Sanctions Violations
Anonymous SEC Whistleblower Receives $3.6 Million Award
Competitor Recovers Damages From FCPA Violator In Post-Enforcement Civil Litigation
Fraudulent Acquisition of Healthcare Entity Did Not Implicate Later Claims for Medicare Reimbursement; United States District Court for the District of New Jersey No. 3:19-cv-18753-FLW-ZNQ, U.S. ex rel. David Freedman v. Bayada Home Health Care Inc., et al.
DOJ Announces $22 Million False Claims Act Settlement with the University of Miami for Provider-Based and Lab Billing Issues
Massachusetts Man Admits to Defrauding GSA with Fake Expenses, Contracts for Family
Georgia Man Charged with Claiming Maryland Unemployment Benefits for Illinois Residents
Relators Alleged Inside Information about Billing Practices, but Provided No Details of Improper Physician Payments, Claims to Medicare; United States Court of Appeals for the Eleventh Circuit, Estate of Debbie Helmly, et al. v. Bethany Hospice and Palliative Care of Coastal Georgia LLC, et al.
Magistrate Grants Motion for Leave to Amend over Defendants’ Futility Argument; United States District Court for the Middle District of Tennessee, Nashville Division, No. 3:17-cv-00902, U.S. and Tennessee ex rel. Jeffrey Liebman and David Stern M.D. v. Methodist Le Bonheur Healthcare, et al.
How to Know the Government Is Investigating You or Your Company in Connection with COVID Relief Funds
Former Executives at University Hospital System Report the University for Fraudulently Maximizing Payments It Received Under the Medicare Program, Leading to a $22 Million False Claims Act Settlement and a Payment of a Whistleblower Reward
Pharmacy Owner Sentenced to Prison for TRICARE Fraud
Ninth Circuit Weighs In On Fraud-On-The-FDA Theory, Marketing Devices For Off-Label Use, And Kickbacks
How the Truth Is False: Accurate Prescription Drug Event Data Can Trigger False Claims Act Liability
Court Not Impressed by “Wait and See” Approach to Amending Complaint When Relator Claims He Knew of Allegations All Along; United States District Court for the Eastern District of Pennsylvania No. 16-683, U.S., et al. ex rel. Timothy Sirls v. Kindred Healthcare Inc., et al.
Return to Civil and Criminal Collaboration in White Collar under Biden Administration
Opportunities for Cost Savings Not Evidence of Fraud; United States District Court for the Western District of Oklahoma No. 20-CV-00576-PRW, John D. Adams v. ATAC Services LLC and Science Applications International Corporation
Compliance Programs Need to Face Real Ethical Dilemmas
Emerging False Claims Act Risk In Trade: Recent False Claims Act Developments Increase Trade Exposure (Part III)
Keep reading
